OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
JAK/STAT signaling in diabetic kidney disease
Yingjun Liu, Wenkuan Wang, Jintao Zhang, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 27
Yingjun Liu, Wenkuan Wang, Jintao Zhang, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
Pathomechanisms of Diabetic Kidney Disease
Satyesh K. Sinha, Susanne B. Nicholas
Journal of Clinical Medicine (2023) Vol. 12, Iss. 23, pp. 7349-7349
Open Access | Times Cited: 24
Satyesh K. Sinha, Susanne B. Nicholas
Journal of Clinical Medicine (2023) Vol. 12, Iss. 23, pp. 7349-7349
Open Access | Times Cited: 24
Mechanisms and therapeutic prospect of the JAK-STAT signaling pathway in liver cancer
Junjun Jia, Xuelian Zhou, Qingfei Chu
Molecular and Cellular Biochemistry (2024) Vol. 480, Iss. 1, pp. 1-17
Closed Access | Times Cited: 11
Junjun Jia, Xuelian Zhou, Qingfei Chu
Molecular and Cellular Biochemistry (2024) Vol. 480, Iss. 1, pp. 1-17
Closed Access | Times Cited: 11
Macrophage colony-stimulating factor and its role in the tumor microenvironment: novel therapeutic avenues and mechanistic insights
Yi Li, Yihan Gai, Zhuo Chen, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 10
Yi Li, Yihan Gai, Zhuo Chen, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 10
Repurposing the familiar: Future treatment options against chronic kidney disease
Rohan Bhadange, Anil Bhanudas Gaikwad
Journal of Pharmacy and Pharmacology (2025)
Closed Access | Times Cited: 1
Rohan Bhadange, Anil Bhanudas Gaikwad
Journal of Pharmacy and Pharmacology (2025)
Closed Access | Times Cited: 1
Integrated UPLC-ESI-MS/MS, network pharmacology, and transcriptomics to reveal the material basis and mechanism of Schisandra chinensis Fruit Mixture against diabetic nephropathy
Yuanyuan Deng, Xinyu Ma, Pengfei He, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Yuanyuan Deng, Xinyu Ma, Pengfei He, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Advancements in Diabetic Kidney Disease Management: Integrating Innovative Therapies and Targeted Drug Development
Shaarav Ghose, Matthew Satariano, Saichidroopi Korada, et al.
AJP Endocrinology and Metabolism (2024) Vol. 326, Iss. 6, pp. E791-E806
Closed Access | Times Cited: 6
Shaarav Ghose, Matthew Satariano, Saichidroopi Korada, et al.
AJP Endocrinology and Metabolism (2024) Vol. 326, Iss. 6, pp. E791-E806
Closed Access | Times Cited: 6
A new strategy for Astragaloside IV in the treatment of diabetic kidney disease: Analyzing the regulation of ferroptosis and mitochondrial function of renal tubular epithelial cells
Jun Liu, Kang Yang, Linlan Zhou, et al.
International Immunopharmacology (2024) Vol. 141, pp. 112794-112794
Closed Access | Times Cited: 4
Jun Liu, Kang Yang, Linlan Zhou, et al.
International Immunopharmacology (2024) Vol. 141, pp. 112794-112794
Closed Access | Times Cited: 4
Critical Analysis of Hot Topics in Diabetic Nephropathy related Experimental Research: A Bibliometric Analysis From 2018 to 2024
Jia Yong-Xia, Yunfei Gu, Lijun Wang, et al.
Journal of Tissue Viability (2025) Vol. 34, Iss. 1, pp. 100854-100854
Open Access
Jia Yong-Xia, Yunfei Gu, Lijun Wang, et al.
Journal of Tissue Viability (2025) Vol. 34, Iss. 1, pp. 100854-100854
Open Access
Butyrolactone I blocks the transition of acute kidney injury to chronic kidney disease in mice by targeting JAK1
Zijun Zhang, Min Jin Ha, Changxing Qi, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access
Zijun Zhang, Min Jin Ha, Changxing Qi, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access
Potential Modulatory Effects of Hesperidin on the JAK /STAT Pathway in Mesangial Proliferative Glomerulonephritis
Tang Ying-chun, Jing Zhang, Zhengxiang Wang, et al.
Chemical Biology & Drug Design (2025) Vol. 105, Iss. 2
Closed Access
Tang Ying-chun, Jing Zhang, Zhengxiang Wang, et al.
Chemical Biology & Drug Design (2025) Vol. 105, Iss. 2
Closed Access
Spotlight on amino acid changing mutations in the JAK-STAT pathway: from disease-specific mutation to general mutation databases
Markus Hoffmann, Lothar Hennighausen
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Markus Hoffmann, Lothar Hennighausen
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Crosstalk between ferroptosis and innate immune in diabetic kidney disease: mechanisms and therapeutic implications
Jinyang Wang, Haonan Shi, Ye Seul Yang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Jinyang Wang, Haonan Shi, Ye Seul Yang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Ameliorative effects of wine-steamed Songaria Cynomorium Herb: Chemical characterization by UPLC-Q-TOF-MS and modulation of pathophysiology and JAK/STAT signaling pathway in kidney-Yang deficient rats
Wenjing Ren, Yue Zhou, Jiahui Zhao, et al.
Fitoterapia (2025) Vol. 182, pp. 106478-106478
Closed Access
Wenjing Ren, Yue Zhou, Jiahui Zhao, et al.
Fitoterapia (2025) Vol. 182, pp. 106478-106478
Closed Access
Isoquercitrin Alleviates Diabetic Nephropathy by Inhibiting STAT3 Phosphorylation and Dimerization
Chen Xuan, Donghui Chen, Shuangna Zhang, et al.
Advanced Science (2025)
Open Access
Chen Xuan, Donghui Chen, Shuangna Zhang, et al.
Advanced Science (2025)
Open Access
Diabetic Kidney Disease: Disease Progression Driven by Positive Feedback Loops and Therapeutic Strategies Targeting Pathogenic Pathways
Gaozhi P Mo, Yao Zhu, Yue You, et al.
Diabetes Metabolic Syndrome and Obesity (2025) Vol. Volume 18, pp. 1073-1085
Open Access
Gaozhi P Mo, Yao Zhu, Yue You, et al.
Diabetes Metabolic Syndrome and Obesity (2025) Vol. Volume 18, pp. 1073-1085
Open Access
Quantitative Assessment of Intracellular Effectors and Cellular Response in RAGE Activation
Vinitha Deepu, Vikrant Rai, Devendra K Agrawal
Archives of Internal Medicine Research (2024) Vol. 07, Iss. 02
Open Access | Times Cited: 3
Vinitha Deepu, Vikrant Rai, Devendra K Agrawal
Archives of Internal Medicine Research (2024) Vol. 07, Iss. 02
Open Access | Times Cited: 3
Molecular signaling pathways in doxorubicin-induced nephrotoxicity and potential therapeutic agents
Changxu Lu, Jinwen Wei, Can Gao, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113373-113373
Closed Access | Times Cited: 2
Changxu Lu, Jinwen Wei, Can Gao, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113373-113373
Closed Access | Times Cited: 2
Role of inflammation in the progression of diabetic kidney disease
Arunita Chatterjee, Jacqueline Tumarin, Sharma Prabhakar
Vessel Plus (2024)
Open Access | Times Cited: 2
Arunita Chatterjee, Jacqueline Tumarin, Sharma Prabhakar
Vessel Plus (2024)
Open Access | Times Cited: 2
The Role of Autophagy in Type 2 Diabetic Kidney Disease Management
Che-Hao Tseng, Kavya M. Shah, I‐Jen Chiu, et al.
Cells (2023) Vol. 12, Iss. 23, pp. 2691-2691
Open Access | Times Cited: 5
Che-Hao Tseng, Kavya M. Shah, I‐Jen Chiu, et al.
Cells (2023) Vol. 12, Iss. 23, pp. 2691-2691
Open Access | Times Cited: 5
Hederagenin Improves Adriamycin-induced Nephropathy by Inhibiting the JAK/STAT Signaling Pathway
Xia Zhong, Jian Jia, Ruizhi Tan, et al.
Integrative Medicine in Nephrology and Andrology (2024) Vol. 11, Iss. 2
Closed Access | Times Cited: 1
Xia Zhong, Jian Jia, Ruizhi Tan, et al.
Integrative Medicine in Nephrology and Andrology (2024) Vol. 11, Iss. 2
Closed Access | Times Cited: 1
Role of Extracellular Vesicle-Derived Noncoding RNAs in Diabetic Kidney Disease
Miao Hu, Xiahong Shen, Ling Zhou
Kidney Diseases (2024) Vol. 10, Iss. 4, pp. 303-312
Open Access | Times Cited: 1
Miao Hu, Xiahong Shen, Ling Zhou
Kidney Diseases (2024) Vol. 10, Iss. 4, pp. 303-312
Open Access | Times Cited: 1
Lycorine relieves the CCl4-induced liver fibrosis mainly via the JAK2/STAT3 and PI3K/AKT signaling pathways
Yue Tang, Zaisheng Zhu, Mengying Li, et al.
Toxicology and Applied Pharmacology (2024) Vol. 489, pp. 117017-117017
Closed Access | Times Cited: 1
Yue Tang, Zaisheng Zhu, Mengying Li, et al.
Toxicology and Applied Pharmacology (2024) Vol. 489, pp. 117017-117017
Closed Access | Times Cited: 1
Protective role of the curcumin derivative, FM0807, in regulating JAK2/STAT3 and TGF-β1/SMAD2/3 signaling pathways in glomerular mesangial cells and renal function in db/db mice
Nanwen Zhang, Duoduo Lin, Honglin Wang, et al.
Acta Materia Medica (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 1
Nanwen Zhang, Duoduo Lin, Honglin Wang, et al.
Acta Materia Medica (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 1
Alterations in the Levels of Urinary Exosomal MicroRNA-183-5p and MicroRNA-125a-5p in Individuals with Type 2 Diabetes Mellitus
Yixuan Fang, Shiyi Sun, Jing Wu, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2608-2608
Open Access | Times Cited: 1
Yixuan Fang, Shiyi Sun, Jing Wu, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2608-2608
Open Access | Times Cited: 1
Bone marrow mesenchymal stem cell exosomes suppress JAK/STAT signaling pathway in acute myeloid leukemia in vitro
Sahar Jalilivand, Maryam Nabigol, Mehdi Bakhtiyaridovvombaygi, et al.
Blood Research (2024) Vol. 59, Iss. 1
Open Access | Times Cited: 1
Sahar Jalilivand, Maryam Nabigol, Mehdi Bakhtiyaridovvombaygi, et al.
Blood Research (2024) Vol. 59, Iss. 1
Open Access | Times Cited: 1
